Literature DB >> 24422908

Nail Psoriasis, the unknown burden of disease.

K M G Klaassen1, P C M van de Kerkhof, M C Pasch.   

Abstract

BACKGROUND: Psoriasis can be found at several different localizations which may be of various impact on patients' quality of life (QoL). One of the easy visible, and difficult to conceal localizations are the nails.
OBJECTIVE: To achieve more insight into the QoL of psoriatic patients with nail psoriasis, and to characterize the patients with nail involvement which are more prone to the impact of the nail alterations caused by psoriasis.
METHOD: A self-administered questionnaire was distributed to all members (n = 5400) of the Dutch Psoriasis Association. The Dermatology Life Quality Index (DLQI) and the Nail Psoriasis Quality of life 10 (NPQ10) score were included as QoL measures. Severity of cutaneous lesions was determined using the self-administered psoriasis area and severity index (SAPASI).
RESULTS: Patients with nail psoriasis scored significantly higher mean scores on the DLQI (4.9 vs. 3.7, P = <0.001) and showed more severe psoriasis (SAPASI, 6.6 vs. 5.3, P = <0.001). Patients with coexistence of nail bed and nail matrix features showed higher DLQI scores compared with patients with involvement of one of the two localizations exclusively (5.3 vs. 4.2 vs. 4.3, P = 0.003). Patients with only nail bed alterations scored significant higher NPQ10 scores when compared with patients with only nail matrix features. Patients with psoriatic arthritis (PsA) and nail psoriasis experiences more impairments compared with nail psoriasis patients without PsA (DLQI 5.5 vs. 4.3, NPQ10 13.3 vs. 7.0). Females scored higher mean scores on all QoL scores.
CONCLUSION: Greater attention should be paid to the possible impact nail abnormalities have on patients with nail psoriasis, which can be identified by nail psoriasis specific questionnaires such as the NPQ10. As improving the severity of disease may have a positive influence on QoL, the outcome of QoL measurements should be taken into account when deciding on treatment strategies.
© 2014 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2014        PMID: 24422908     DOI: 10.1111/jdv.12368

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  15 in total

1.  Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.

Authors:  Peter Foley; Kenneth Gordon; Christopher E M Griffiths; Yasmine Wasfi; Bruce Randazzo; Michael Song; Shu Li; Yaung-Kaung Shen; Andrew Blauvelt
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

2.  Early Visible Improvements during K101-03 Treatment: An Open-Label Multicenter Clinical Investigation in Patients with Onychomycosis and/or Nail Psoriasis.

Authors:  Bianca Maria Piraccini; Michela Starace; Anders Toft
Journal:  Dermatology       Date:  2017-08-05       Impact factor: 5.366

3.  Racial, Ethnic, and Sex Disparities in Nail Psoriasis Clinical Trials: A Systematic Review.

Authors:  Jose W Ricardo; Yuqing Qiu; Shari R Lipner
Journal:  Skin Appendage Disord       Date:  2022-01-14

4.  Comparison of the Objective Severity and the Esthetic Perception of Nail Symptoms in Psoriasis.

Authors:  Júlia Szebényi; Péter Oláh; Rolland Gyulai
Journal:  Skin Appendage Disord       Date:  2022-02-14

5.  Psoriatic nail involvement and its relationship with distal interphalangeal joint disease.

Authors:  T L Lai; H T Pang; Y Y Cheuk; M L Yip
Journal:  Clin Rheumatol       Date:  2016-06-01       Impact factor: 2.980

6.  Serum levels of TNF- α , IL-12/23 p40, and IL-17 in psoriatic patients with and without nail psoriasis: a cross-sectional study.

Authors:  Aikaterini Kyriakou; Aikaterini Patsatsi; Timoleon-Achilleas Vyzantiadis; Dimitrios Sotiriadis
Journal:  ScientificWorldJournal       Date:  2014-12-31

Review 7.  Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective.

Authors:  Lorenzo Mantovani; Massimo Medaglia; Patrizio Piacentini; Marcella Tricca; Gino Antonio Vena; Antonietta Vozza; Gabriella Castellino; Alessandro Roccia
Journal:  Dermatol Ther (Heidelb)       Date:  2016-04-15

8.  The Impact of Nail Psoriasis and Treatment on Quality of Life: A Systematic Review.

Authors:  Claire R Stewart; Leah Algu; Rakhshan Kamran; Cameron F Leveille; Khizar Abid; Charlene Rae; Shari R Lipner
Journal:  Skin Appendage Disord       Date:  2021-01-22

9.  Serum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity.

Authors:  Aikaterini Kyriakou; Aikaterini Patsatsi; Timoleon-Achilleas Vyzantiadis; Dimitrios Sotiriadis
Journal:  J Immunol Res       Date:  2014-12-21       Impact factor: 4.818

Review 10.  Nail Psoriasis: A Review of Treatment Options.

Authors:  Marcel C Pasch
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.